WILLIAM TROST: Open Payments
NPI 1528025822 · DANVILLE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$438 in 21 payments from 10 companies in 2025. Trend: 2023 $79 · 2024 $284 · 2025 $438
Food & beverage: $438
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 4 | $89 |
| Axsome Therapeutics, Inc. | 3 | $69 |
| Alkermes, Inc. | 3 | $58 |
| ABBVIE INC. | 3 | $56 |
| E.R. Squibb & Sons, L.L.C. | 2 | $48 |
| Janssen Pharmaceuticals, Inc | 2 | $42 |
| Biogen, Inc. | 1 | $23 |
| Lilly USA, LLC | 1 | $18 |
| Lundbeck LLC | 1 | $17 |
| Dexcom, Inc. | 1 | $17 |
Products named: Auvelity, VRAYLAR, COBENFY, ABILIFY MAINTENA, INVEGA SUSTENNA, ARISTADA, REXULTI, ABILIFY ASIMTUFII.
Industry payments across VA — which companies pay providers there.
